TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+23.87%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$791M
AUM Growth
+$791M
(-32%)
Cap. Flow
-$500M
Cap. Flow
% of AUM
-63.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
|
$35.7M |
Top Sells
| 1 |
Relay Therapeutics
RLAY
|
$439M |
| 2 |
Revolution Medicines
RVMD
|
$68.8M |
| 3 |
Nurix Therapeutics
NRIX
|
$28.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.1B
| $253M | 32.06% |
5,524,031
-1,500,000
| -21% | -$68.8M |
|
2
Pliant Therapeutics
PLRX
$101M
| $230M | 29.05% |
5,839,160
| – | – |
|
|
3
Nurix Therapeutics
NRIX
$714M
| $140M | 17.73% |
4,508,333
-914,216
| -17% | -$28.4M |
|
4
Fulcrum Therapeutics
FULC
$351M
| $70.2M | 8.88% |
5,962,202
| – | – |
|
|
DBTX
5
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $35.7M | 4.51% |
+3,139,685
| New | +$35.7M |
|
|
JNCE
6
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $31.3M | 3.96% |
3,048,780
| – | – |
|
7
Voyager Therapeutics
VYGR
$186M
| $30.1M | 3.81% |
6,391,176
| – | – |
|
|
8
Relay Therapeutics
RLAY
$619M
| – | – |
-10,551,115
| Closed | -$439M |
|